These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19336541)

  • 21. Palladin expression is a conserved characteristic of the desmoplastic tumor microenvironment and contributes to altered gene expression.
    Cannon AR; Owen MK; Guerrero MS; Kerber ML; Goicoechea SM; Hemstreet KC; Klazynski B; Hollyfield J; Chang EH; Hwang RF; Otey CA; Kim HJ
    Cytoskeleton (Hoboken); 2015 Aug; 72(8):402-11. PubMed ID: 26333695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome.
    Lener MR; Kashyap A; Kluźniak W; Cybulski C; Soluch A; Pietrzak S; Huzarski T; Gronwald J; Lubiński J
    Cancer Res Treat; 2017 Apr; 49(2):430-436. PubMed ID: 27488870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic Cancer.
    Goldstein JB; Zhao L; Wang X; Ghelman Y; Overman MJ; Javle MM; Shroff RT; Varadhachary GR; Wolff RA; McAllister F; Futreal A; Fogelman DR
    Clin Cancer Res; 2020 Mar; 26(6):1385-1394. PubMed ID: 31871297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No evidence for germline mutations of the LKB1/STK11 gene in familial pancreatic carcinoma.
    Grützmann R; McFaul C; Bartsch DK; Sina-Frey M; Rieder H; Koch R; McCarthy E; Greenhalf W; Neoptolemos JP; Saeger HD; Pilarsky C
    Cancer Lett; 2004 Oct; 214(1):63-8. PubMed ID: 15331174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of palladin is associated with disease progression in metastatic high-grade serous carcinoma.
    Davidson B; Bock AJ; Holth A; Nymoen DA
    Cytopathology; 2020 Nov; 31(6):572-578. PubMed ID: 32741023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreatic cancer.
    Real FX; Malats N; Lesca G; Porta M; Chopin S; Lenoir GM; Sinilnikova O;
    Gut; 2002 May; 50(5):653-7. PubMed ID: 11950811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BRCA2 germline mutations in familial pancreatic carcinoma.
    Hahn SA; Greenhalf B; Ellis I; Sina-Frey M; Rieder H; Korte B; Gerdes B; Kress R; Ziegler A; Raeburn JA; Campra D; Grützmann R; Rehder H; Rothmund M; Schmiegel W; Neoptolemos JP; Bartsch DK
    J Natl Cancer Inst; 2003 Feb; 95(3):214-21. PubMed ID: 12569143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of breast cancer susceptibility variants with risk of pancreatic cancer.
    Couch FJ; Wang X; McWilliams RR; Bamlet WR; de Andrade M; Petersen GM
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3044-8. PubMed ID: 19843670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcome.
    Couch FJ; Wang X; Bamlet WR; de Andrade M; Petersen GM; McWilliams RR
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):251-7. PubMed ID: 20056645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleotide excision repair pathway polymorphisms and pancreatic cancer risk: evidence for role of MMS19L.
    McWilliams RR; Bamlet WR; de Andrade M; Rider DN; Cunningham JM; Petersen GM
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1295-302. PubMed ID: 19318433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of common variants in BRCA2 and MAP2K4 for susceptibility to sporadic pancreatic cancer.
    Huang L; Wu C; Yu D; Wang C; Che X; Miao X; Zhai K; Chang J; Jiang G; Yang X; Cao G; Hu Z; Zhou Y; Zuo C; Wang C; Zhang X; Zhou Y; Yu X; Dai W; Li Z; Shen H; Liu L; Chen Y; Zhang S; Wang X; Liu Y; Sun M; Cao W; Gao J; Ma Y; Zheng X; Cheung ST; Jia Y; Tan W; Wu T; Lin D
    Carcinogenesis; 2013 May; 34(5):1001-5. PubMed ID: 23299404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isoform-specific upregulation of palladin in human and murine pancreas tumors.
    Goicoechea SM; Bednarski B; Stack C; Cowan DW; Volmar K; Thorne L; Cukierman E; Rustgi AK; Brentnall T; Hwang RF; McCulloch CA; Yeh JJ; Bentrem DJ; Hochwald SN; Hingorani SR; Kim HJ; Otey CA
    PLoS One; 2010 Apr; 5(4):e10347. PubMed ID: 20436683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial pancreatic cancer.
    Klein AP; Hruban RH; Brune KA; Petersen GM; Goggins M
    Cancer J; 2001; 7(4):266-73. PubMed ID: 11561603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on familial pancreatic cancer.
    Lynch HT; Brand RE; Deters CA; Fusaro RM
    Curr Gastroenterol Rep; 2001 Apr; 3(2):121-8. PubMed ID: 11276379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Palladin is a marker of liver metastasis in primary pancreatic endocrine carcinomas.
    Henderson-Jackson EB; Helm J; Strosberg J; Nasir NA; Yeatman TJ; Kvols LK; Coppola D; Nasir A
    Anticancer Res; 2011 Sep; 31(9):2957-62. PubMed ID: 21868544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial pancreatic cancer: Concept, management and issues.
    Matsubayashi H; Takaori K; Morizane C; Maguchi H; Mizuma M; Takahashi H; Wada K; Hosoi H; Yachida S; Suzuki M; Usui R; Furukawa T; Furuse J; Sato T; Ueno M; Kiyozumi Y; Hijioka S; Mizuno N; Terashima T; Mizumoto M; Kodama Y; Torishima M; Kawaguchi T; Ashida R; Kitano M; Hanada K; Furukawa M; Kawabe K; Majima Y; Shimosegawa T
    World J Gastroenterol; 2017 Feb; 23(6):935-948. PubMed ID: 28246467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial pancreatic cancer.
    Shi C; Hruban RH; Klein AP
    Arch Pathol Lab Med; 2009 Mar; 133(3):365-74. PubMed ID: 19260742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CDKN2A is the main susceptibility gene in Italian pancreatic cancer families.
    Ghiorzo P; Fornarini G; Sciallero S; Battistuzzi L; Belli F; Bernard L; Bonelli L; Borgonovo G; Bruno W; De Cian F; Decensi A; Filauro M; Faravelli F; Gozza A; Gargiulo S; Mariette F; Nasti S; Pastorino L; Queirolo P; Savarino V; Varesco L; Scarrà GB;
    J Med Genet; 2012 Mar; 49(3):164-70. PubMed ID: 22368299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial association of pancreatic cancer with other malignancies in Swedish families.
    Hiripi E; Lorenzo Bermejo J; Li X; Sundquist J; Hemminki K
    Br J Cancer; 2009 Nov; 101(10):1792-7. PubMed ID: 19826425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic.
    Borecka M; Zemankova P; Vocka M; Soucek P; Soukupova J; Kleiblova P; Sevcik J; Kleibl Z; Janatova M
    Cancer Genet; 2016 May; 209(5):199-204. PubMed ID: 27106063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.